Alembic Pharmaceuticals Ltd
APLLTD
Company Profile
Business description
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities.
Contact
Alembic Road
VadodaraGJ390 003
INDT: +91 2652280550
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
16,571
Stocks News & Analysis
stocks
We take a different view to market on ASX bloodbath
Sales growth at CSL was lower than expected but streamlining the business has its perks.
stocks
BHP earnings weaker with lower iron ore prices more than offsetting higher copper volumes
Results were softer than expected.
stocks
Moated ASX player makes moves to support growth in China
a2Milk announced an acquisition and a divestiture as it aims to take a bigger slice of China’s baby formula market.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,173.80 | 59.70 | -0.65% |
| CAC 40 | 7,979.08 | 95.03 | 1.21% |
| DAX 40 | 24,423.07 | 108.30 | 0.45% |
| Dow JONES (US) | 44,922.27 | 10.45 | 0.02% |
| FTSE 100 | 9,189.22 | 31.48 | 0.34% |
| HKSE | 25,122.90 | 53.95 | -0.21% |
| NASDAQ | 21,314.95 | 314.82 | -1.46% |
| Nikkei 225 | 43,546.29 | 168.02 | -0.38% |
| NZX 50 Index | 12,938.63 | 9.95 | 0.08% |
| S&P 500 | 6,411.37 | 37.78 | -0.59% |
| S&P/ASX 200 | 8,896.20 | 63.10 | -0.70% |
| SSE Composite Index | 3,727.29 | 0.74 | -0.02% |